For Infrastructure & Operations Professionals

Primary Analyst Photo	Document Information	Rate this Document
	September 9, 2009 Case Study: CryoPort Turns To Cloud Computing To Develop Tomorrow's New Vaccines by James Staten with Lauren E. Nelson, Simon Yates	Average: 9  (1 rating)

This is an excerpt

Executive Summary

New-vaccine and pharmaceutical delivery is a very time-sensitive application to say the least, especially when uncertainty can skew test results. CryoPort and KLATU Networks teamed up to build a biological package tracking system that leveraged Amazon Web Services' Elastic Compute Cloud (EC2) to eliminate shipping and storage uncertainty from pharmaceutical transport — and do so at scale. This unique system aggregates all the necessary shipping, customs forms, and temperature logs throughout the packages' journey so the receiving hospital can be confident that the vaccines and pharmaceuticals were handled properly and remain viable for use. By leveraging cloud computing, KLATU can confidently state that the system will be able to scale to more than 40 million shipments per year and thousands of simultaneous users.

This is an excerpt